GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BNC Korea Co Ltd (XKRX:256840) » Definitions » EV-to-Revenue

BNC Korea Co (XKRX:256840) EV-to-Revenue : 3.74 (As of Jun. 22, 2024)


View and export this data going back to 2016. Start your Free Trial

What is BNC Korea Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, BNC Korea Co's enterprise value is ₩304,956 Mil. BNC Korea Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩81,571 Mil. Therefore, BNC Korea Co's EV-to-Revenue for today is 3.74.

The historical rank and industry rank for BNC Korea Co's EV-to-Revenue or its related term are showing as below:

XKRX:256840' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.57   Med: 8.01   Max: 58.03
Current: 3.74

During the past 8 years, the highest EV-to-Revenue of BNC Korea Co was 58.03. The lowest was 1.57. And the median was 8.01.

XKRX:256840's EV-to-Revenue is ranked worse than
68.86% of 1018 companies
in the Drug Manufacturers industry
Industry Median: 2.21 vs XKRX:256840: 3.74

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-22), BNC Korea Co's stock price is ₩5710.00. BNC Korea Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩954.93. Therefore, BNC Korea Co's PS Ratio for today is 5.98.


BNC Korea Co EV-to-Revenue Historical Data

The historical data trend for BNC Korea Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BNC Korea Co EV-to-Revenue Chart

BNC Korea Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial 3.97 11.82 56.15 4.92 2.10

BNC Korea Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.98 1.93 2.16 2.10 5.20

Competitive Comparison of BNC Korea Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, BNC Korea Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BNC Korea Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BNC Korea Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where BNC Korea Co's EV-to-Revenue falls into.



BNC Korea Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

BNC Korea Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=304955.895/81570.746
=3.74

BNC Korea Co's current Enterprise Value is ₩304,956 Mil.
BNC Korea Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩81,571 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BNC Korea Co  (XKRX:256840) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

BNC Korea Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=5710.00/954.93
=5.98

BNC Korea Co's share price for today is ₩5710.00.
BNC Korea Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩954.93.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BNC Korea Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of BNC Korea Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


BNC Korea Co (XKRX:256840) Business Description

Traded in Other Exchanges
N/A
Address
62 Seongseogongdan-ro 11-gil, Dalseo-gu, No 405, Structure 1, Daegu Techno Park Venture Factory, Daegu, KOR, 42713
BNC Korea Co Ltd is a Korean healthcare company. The company is engaged in manufacturing medicinal chemicals, antibiotics, and biological products. IIts product offering includes cutegel, cutegel lidocaine, FLORE lidocaine, ChungA-an, cutegel-M under the HA filler product line. While it also offers Skin booster filler, hibarry, gentaQ, and I.st products.

BNC Korea Co (XKRX:256840) Headlines

No Headlines